Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Asia Congress 2024

Targeting DNA damage response (DDR): Next generation drugs and the importance of biomarkers

Refining patient selection: Benefits and risks of treating unselected patient groups

Date

08 Dec 2024

Session

Targeting DNA damage response (DDR): Next generation drugs and the importance of biomarkers

Topics

Targeted Therapy

Tumour Site

Breast Cancer

Presenters

Seock-Ah Im

Authors

S. Im

Author affiliations

  • Internal Medicine Dept, SNUH - Seoul National University Hospital, 03080 - Seoul/KR

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Other synthetic lethality targets

Presenter: Ruth Plummer

Session: Targeting DNA damage response (DDR): Next generation drugs and the importance of biomarkers

Resources:

Slides

Webcast

Q&A and discussion

Session: Targeting DNA damage response (DDR): Next generation drugs and the importance of biomarkers

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.